Evidence map›Paper›PMID 27642417›Full record

ReviewThe Pan African medical journal2016

[Neuroendocrine carcinoma of the breast: about a case and review of the literature].

Mariam Affane, Leila Elmorjani, Abdelhamid El Omrani, Fayçal Abbadi, Hanane Rais, Mouna Khouchani

Abstract readCase ReportsReview
In one paragraph

Review in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mariam AffaneService d'Oncologie-Radiothérapie, CHU Mohammed VI de Marrakech, Maroc.
Leila ElmorjaniService d'Oncologie-Radiothérapie, CHU Mohammed VI de Marrakech, Maroc.
Abdelhamid El OmraniService d'Oncologie-Radiothérapie, CHU Mohammed VI de Marrakech, Maroc.
Fayçal AbbadiService d'Anatomo-Pathologie, CHU Mohammed VI de Marrakech, Maroc.
Hanane RaisService d'Anatomo-Pathologie, CHU Mohammed VI de Marrakech, Maroc.
Mouna KhouchaniService d'Oncologie-Radiothérapie, CHU Mohammed VI de Marrakech, Maroc.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primitive neuroendocrine carcinomas of the breast are rare tumors. They are now included in the latest WHO classification of tumors of the breast. We report the case of a 39-year old patient with tumor located in the breast. It was a locally advanced tumor that required mastectomy and ipsilateral axillary node dissection. Adjuvant chemotherapy was indicated. The evolution was marked by local progression. The patient died in a state of febrile pancytopenia after a one-year survival.

Indexed as

AdultBreast NeoplasmsCarcinoma, NeuroendocrineChemotherapy, AdjuvantDisease ProgressionFemaleHumansLymph Node ExcisionMastectomyPancytopeniabreast tumorNeuroendocrine carcinomaprognosistreatment

Identifiers

PMID27642417
PMCPMC5012787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.